Skip to main content

Table 3 Levels of miR-17-3p, CEA, and CA19.9 in studied population (patients and control)

From: Role of circulating miRNA-17-3P as a potential diagnostic biomarker for sporadic colon cancer in Egyptian cohort

miRNAPatients (n = 50)Control (n = 25)Up
Min.–max.1.74–32.450.27–3.415.00*> 0.001*
Mean ± SD9.07 ± 7.250.95 ± 0.63
Median6.850.88
CEA
 Min.–max.0.10–110.00.10–14.0465.500.073
 Mean ± SD8.63 ± 20.832.94 ± 3.24
 Median2.902.20
CA19.9
 Min.–max.0.25–700.05.0–30.0302.50*< 0.001*
 Mean ± SD39.40 ± 97.619.56 ± 5.20
 Median20.458.0